NYSE:LLY - Eli Lilly And Co News Headlines Sign in or create an account to add this stock to your watchlist. Get Started $116.66 -1.32 (-1.12 %) (As of 05/23/2019 02:44 PM ET)Previous Close$117.98Today's Range$116.55 - $117.9452-Week Range$81.61 - $132.13Volume126,739 shsAverage Volume4.29 million shsMarket Capitalization$113.26 billionP/E Ratio21.01Dividend Yield2.21%Beta0.27 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Eli Lilly And Co (NYSE LLY) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlineEli Lilly And Co (LLY) Given Average Rating of "Buy" by Brokerageswww.americanbankingnews.com - May 23 at 2:27 PMShould We Worry About Eli Lilly and Company's (NYSE:LLY) P/E Ratio?finance.yahoo.com - May 22 at 7:05 PMArray BioPharma Gains on Colorectal Cancer Study Successfinance.yahoo.com - May 22 at 7:05 PMEli Lilly's Insulin Lispro Injection available at half the list price of Humalogwww.marketwatch.com - May 22 at 8:34 AMLilly selling half-price version of popular Humalog insulinmarketbeat.com - May 22 at 6:48 AMLilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesionsfinance.yahoo.com - May 21 at 7:13 PMWhy This Biotech Stock Succeeded In Colon Cancer As Others Struggledfinance.yahoo.com - May 21 at 7:13 PMWhy Eli Lilly (LLY) is a Top Dividend Stock for Your Portfoliowww.nasdaq.com - May 20 at 11:41 PMTop Money Manager Recommends Eli Lilly On Recent Market Dipwww.forbes.com - May 19 at 4:15 PMBetter Buy: Eli Lilly vs. Pfizerfinance.yahoo.com - May 19 at 9:07 AMData Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancerfinance.yahoo.com - May 15 at 8:23 PMEli Lilly Announces FDA Approval Of CYRAMZA For New Indicationwww.finanznachrichten.de - May 13 at 8:35 AMLilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinomafinance.yahoo.com - May 13 at 8:35 AMTwo Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpointswww.prnewswire.com - May 7 at 8:14 PMInsider Selling: Eli Lilly And Co (LLY) SVP Sells 7,577 Shares of Stockwww.americanbankingnews.com - May 7 at 2:33 PMEli Lilly And Co Plans Quarterly Dividend of $0.65 (LLY)www.americanbankingnews.com - May 6 at 4:30 PMLilly Declares Second-Quarter 2019 Dividendwww.prnewswire.com - May 6 at 2:37 PMEdited Transcript of LLY earnings conference call or presentation 30-Apr-19 1:00pm GMTfinance.yahoo.com - May 6 at 8:37 AMAAN 2019: Pooled Analyses of Two Emgality® (galcanezumab-gnlm) Phase 3 Studies Show Reduction in Monthly Migraine Headache Days in Low- and High-Frequency Episodic Migraine Subgroupsfinance.yahoo.com - May 6 at 8:37 AMGlobal Cyclin Dependent Kinase 6 Market 2018- Beta Pharma Inc, Eli Lilly And Company, FLX Bio Incwww.marketwatch.com - May 4 at 8:43 AMFlippin Bruce & Porter Inc Buys Norfolk Southern Corp, Sells Eli Lilly and Cofinance.yahoo.com - May 3 at 7:03 PMMigraine drugs cause pain for investorsfinance.yahoo.com - May 3 at 7:03 PMFY2019 Earnings Forecast for Eli Lilly And Co Issued By Cantor Fitzgerald (LLY)www.americanbankingnews.com - May 3 at 9:42 AMGlobal Erectile Dysfunction (ED) Drugs Market to 2023 with Bayer, Eli Lilly and Co, Pfizer, Teva Pharma, & Vivus Dominatingwww.prnewswire.com - May 2 at 8:42 AMLilly to Present New Data at AAN 2019 on Emgality® (galcanezumab-gnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfoliofinance.yahoo.com - May 2 at 8:42 AMEli Lilly And Co (LLY) Given New $133.00 Price Target at BMO Capital Marketswww.americanbankingnews.com - May 1 at 11:13 AMEli Lilly misses on revenue in face of pricing pressures and growing generic competitionfinance.yahoo.com - May 1 at 8:31 AMEli Lilly And Co (LLY) Earning Somewhat Favorable Media Coverage, Study Showswww.americanbankingnews.com - May 1 at 5:52 AMEli Lilly and Company (LLY) Q1 2019 Earnings Call Transcriptwww.fool.com - May 1 at 12:10 AMEli Lilly And Co (LLY) Rating Reiterated by Cantor Fitzgeraldwww.americanbankingnews.com - April 30 at 9:40 PMUPDATE 2-Eli Lilly misses estimates for diabetes drug Trulicity, cuts revenue forecastwww.cnbc.com - April 30 at 6:40 PMWhat's Behind Eli Lilly's Mixed Q1 Resultswww.fool.com - April 30 at 6:40 PMEli Lilly slashes guidance in face of pricing pressures and growing generic competitionwww.marketwatch.com - April 30 at 6:40 PMUS stock Indicators waver on mixed earnings; Alphabet downwww.americanbankingnews.com - April 30 at 5:04 PMUS stock indexes waver on mixed earnings; Alphabet downmarketbeat.com - April 30 at 4:16 PMUS stock Indicators Slide on earnings; Alphabet tumbleswww.americanbankingnews.com - April 30 at 3:04 PMUS stock indexes slip on mixed earnings; Alphabet tumblesmarketbeat.com - April 30 at 2:25 PMEarnings Results: Eli Lilly slashes guidance in face of pricing pressures and growing generic competitionwww.marketwatch.com - April 30 at 11:37 AMEli Lilly And Co (LLY) Issues Earnings Results, Beats Estimates By $0.01 EPSwww.americanbankingnews.com - April 30 at 11:05 AMEli Lilly And Co (LLY) Issues FY19 Earnings Guidancewww.americanbankingnews.com - April 30 at 10:22 AMUPDATE 1-Eli Lilly cuts revenue forecast, shares fallwww.cnbc.com - April 30 at 8:32 AMEli Lilly's stock sinks after earnings beat but revenue comes up short, hurt by Trulicity and Alimta misseswww.marketwatch.com - April 30 at 8:32 AMEli Lilly Reports Better-Than-Expected Earnings but Shares Declinewww.thestreet.com - April 30 at 8:32 AMEli Lilly And Co. Q1 adjusted earnings Beat Estimateswww.finanznachrichten.de - April 30 at 8:32 AMEli Lilly quarterly profit more than triples on Elanco gainwww.cnbc.com - April 30 at 8:32 AMEli Lilly misses estimates for diabetes drug Trulicity, cuts revenue forecastfinance.yahoo.com - April 30 at 8:32 AMEli Lilly And Co (LLY) Updates FY 2019 Earnings Guidancewww.americanbankingnews.com - April 30 at 7:46 AMEarnings Watch: Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Here’s what to expect www.marketwatch.com - April 29 at 4:47 PMTomorrow Is Earnings Day for Big Pharma. Here’s What to Watch.finance.yahoo.com - April 29 at 8:30 AMWeek In Review: Eddingpharm To Pay $375 Million For 2 Lilly Antibiotics And A Suzhou Manufacturing Facilityseekingalpha.com - April 28 at 5:51 PM This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: What does the Dow Jones Industrial Average (DJIA) measure? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.